These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 111486)

  • 1. In vivo and in vitro interaction of Trypanosoma cruzi with mouse macrophages and heart muscle cells--film presentation.
    Ax W; Dyonysius J; Hungerer KD
    Adv Exp Med Biol; 1979; 114():673-6. PubMed ID: 111486
    [No Abstract]   [Full Text] [Related]  

  • 2. Trypanosoma cruzi: uptake and intracellular fate in normal and activated cells.
    Nogueira N; Cohn Z
    Am J Trop Med Hyg; 1977 Nov; 26(6 Pt 2):194-203. PubMed ID: 413447
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance of Trypanosoma cruzi to killing by macrophages.
    Kress Y; Bloom BR; Wittner M; Rowen A; Tanowitz H
    Nature; 1975 Oct; 257(5525):394-6. PubMed ID: 809716
    [No Abstract]   [Full Text] [Related]  

  • 4. Trypanosoma cruzi: peripheral blood monocytes and heart macrophages in the resistance to acute experimental infection in rats.
    Melo RC; Machado CR
    Exp Parasitol; 2001 Jan; 97(1):15-23. PubMed ID: 11207110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages in experimental Chagas' disease.
    Kuhn RE
    Immunol Ser; 1994; 60():495-502. PubMed ID: 8251589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phagocytosis: a defense mechanism against infection with Trypanosoma cruzi.
    Kierszenbaum F; Knecht E; Budzko DB; Pizzimenti MC
    J Immunol; 1974 May; 112(5):1839-44. PubMed ID: 4361979
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanosoma cruzi infection.
    Melo RC
    J Cell Mol Med; 2009 Feb; 13(2):279-94. PubMed ID: 18624767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation.
    La Flamme AC; Kahn SJ; Rudensky AY; Van Voorhis WC
    Eur J Immunol; 1997 Dec; 27(12):3085-94. PubMed ID: 9464791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCG-induced resistance in Trypanosoma cruzi experimental infections.
    Bertelli MS; Alcantara A; Brener Z
    Tropenmed Parasitol; 1981 Jun; 32(2):93-6. PubMed ID: 6789512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic lymphocytes treated with IgG from Trypanosoma cruzi infection increase TNF-alpha secretion and reduce parasite replication in macrophages.
    Montalvão F; Almeida GM; Silva EM; Borges VM; Vasconcellos R; Takiya CM; Lopes MF; Nunes MP; DosReis GA
    Eur J Immunol; 2010 Feb; 40(2):417-25. PubMed ID: 19950177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and Phenotypic Characterization of Inflammatory Cells from Clinical Samples: Purification of Macrophages from Trypanosoma cruzi-Infected Hearts.
    Eberhardt N; Sanmarco LM; Aoki MP
    Methods Mol Biol; 2019; 1955():381-395. PubMed ID: 30868542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of leukotriene C4 on macrophage association with and intracellular fate of Trypanosoma cruzi.
    Wirth JJ; Kierszenbaum F
    Mol Biochem Parasitol; 1985 Apr; 15(1):1-10. PubMed ID: 2859521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi recognition by macrophages and muscle cells: perspectives after a 15-year study.
    De Araujo-Jorge TC; Barbosa HS; Meirelles MN
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():43-56. PubMed ID: 1342716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(A)-containing RNA from the spleens of mice with Chagas' disease triggers in vitro macrophage resistance to Trypanosoma cruzi.
    Bertolini MC; De Lucca FL
    J Protozool; 1986 Feb; 33(1):81-4. PubMed ID: 2420985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6 promotes M2 macrophage polarization by modulating purinergic signaling and regulates the lethal release of nitric oxide during Trypanosoma cruzi infection.
    Sanmarco LM; Ponce NE; Visconti LM; Eberhardt N; Theumer MG; Minguez ÁR; Aoki MP
    Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):857-869. PubMed ID: 28087471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).
    Silva JS; Twardzik DR; Reed SG
    J Exp Med; 1991 Sep; 174(3):539-45. PubMed ID: 1908509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chagas cardiomyopathy (Trypanosoma cruzi): does prolactin play a role?
    Pearson RD
    Cytokine Growth Factor Rev; 2007; 18(3-4):209. PubMed ID: 17512239
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental Chagas disease: phagocytosis of apoptotic lymphocytes deactivates macrophages and fuels parasite growth.
    Lopes MF; DosReis GA
    Apoptosis; 2000 Jun; 5(3):221-4. PubMed ID: 11225843
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
    Basso B; Marini V
    Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked increase in Ia-bearing macrophages during Trypanosoma cruzi infection.
    Behbehani K; Pan SC; Unanue ER
    Clin Immunol Immunopathol; 1981 May; 19(2):190-5. PubMed ID: 6784986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.